We are live on ! Find out more
CNSP icon

CNS Pharmaceuticals
CNSP

12 hedge funds and large institutions have $351K invested in CNS Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 6 → 12 (+6)

0% more ownership

Funds ownership: 0% → 0% (+0%)

17% less capital invested

Capital invested by funds: $425K → $351K (-$74.4K)

Holders
12
Holders Change
+6
Holders Change %
+100%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$174K
2
Citadel Advisors
Citadel Advisors
Florida
+$43.6K
3
VF
Virtu Financial
New York
+$43.6K
4
HF
HRT Financial
New York
+$14.5K
5
Jane Street
Jane Street
New York
+$14.5K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$171K +$174K +12 +300%
VF
2
Virtu Financial
New York
$34K +$43.6K +3 New
Citadel Advisors
3
Citadel Advisors
Florida
$33K +$43.6K +3 New
SAF
4
Smith Anglin Financial
Texas
$32.7K +$14.5K +1 +50%
Vanguard Group
5
Vanguard Group
Pennsylvania
$21.1K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$10.2K – – –
Jane Street
7
Jane Street
New York
$9.91K +$14.5K +1 New
State Street
8
State Street
Massachusetts
$8.16K – – –
TSS
9
Two Sigma Securities
New York
$7.89K +$14.5K +1 New
HF
10
HRT Financial
New York
$7K +$14.5K +1 New
FWA
11
FSM Wealth Advisors
Ohio
$6.91K – – –
XT
12
XTX Topco
Cayman Islands
$6.78K +$14.5K +1 New
TRCT
13
Tower Research Capital (TRC)
New York
$2.45K – – –
Bank of America
14
Bank of America
North Carolina
$282 – – –
Wells Fargo
15
Wells Fargo
California
$87 – – –
Morgan Stanley
16
Morgan Stanley
New York
$24 – – –
GRP
17
Global Retirement Partners
California
$19 – – –
Fidelity Investments
18
Fidelity Investments
Massachusetts
$5 – – –
Renaissance Technologies
19
Renaissance Technologies
New York
– -$14K – –

CNSP Hedge Fund Activity: Q1 2024 in Review

12 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in CNS Pharmaceuticals (CNSP) for Q1 2024, worth a combined $351K — down 17% from $425K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CNSP positions and 0 closed out — a net gain of 6 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, adding an estimated $174K. The largest seller was Renaissance Technologies, cutting an estimated $14K.

  • 12 institutional investors held CNS Pharmaceuticals (CNSP) as of Q1 2024, up from 6 in Q4 2023.
  • Funds reported $351K of CNS Pharmaceuticals stock for Q1 2024, down 17% quarter-over-quarter.
  • 6 funds opened new CNS Pharmaceuticals positions in Q1 2024 and 0 closed out, a net change of +6 holders.
  • The largest CNS Pharmaceuticals buyer in Q1 2024 was Armistice Capital, an estimated $174K added.
  • The largest CNS Pharmaceuticals seller in Q1 2024 was Renaissance Technologies, an estimated $14K sold.

Based on aggregated 13F filings for Q1 2024.